NCT07156227 2026-03-18
Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma
National Cancer Institute (NCI)
Phase 1 Not yet recruiting
National Cancer Institute (NCI)
Fujian Cancer Hospital
Baptist Health South Florida
Institute of Hematology & Blood Diseases Hospital, China
Affidea Nu-med Center of Oncological DIagnostics and Therapy
Memorial Sloan Kettering Cancer Center
Brigham and Women's Hospital
Sun Yat-sen University
Tianjin Medical University Cancer Institute and Hospital
Washington University School of Medicine
Sun Yat-sen University